骨膜过表达PTHrP促进牙槽骨形成
本研究利用rAAV9-Pthlh载体单次黏膜下注射大鼠右上颌颊侧牙龈,6周后Micro-CT显示PTHLH侧牙槽骨厚度显著增加,伴骨膜增厚及成骨相关蛋白表达升高。RNA测序提示成骨通路和线粒体自噬上调,原代骨膜干细胞实验验证Pthlh促增殖迁移且依赖线粒体自噬。重复上颌扩弓模型中预防性注射可减轻牙槽嵴吸收。
要点
- 局部注射rAAV9-Pthlh可显著增加大鼠牙槽骨厚度并增厚骨膜。
- PTHrP促进骨膜干细胞增殖迁移,机制涉及线粒体自噬。
- 预防性注射可减轻上颌扩弓模型中的牙槽嵴吸收。
核心结论
- 局部rAAV9-Pthlh注射可增强原位牙槽骨形成,有望预防增龄或正畸干预后的骨开裂。
研究设计与样本
- 采用裂口设计,将rAAV9-Pthlh单次黏膜下注射至大鼠右上颌颊侧牙龈,对侧作为对照。
- 通过体内外Micro-CT、RNA测序、免疫荧光及原代大鼠骨膜干细胞实验评估效应。
- 建立大鼠重复上颌扩弓模型,验证预防性rAAV9-Pthlh注射对牙槽嵴丢失的保护作用。
主要发现
- 转染后6周,Micro-CT显示PTHLH侧牙槽骨厚度显著增加,伴骨膜明显增厚。
- PTHLH侧骨膜中PTHrP、PTH1R、OCN和COL1A1表达升高。
- RNA测序显示颊侧骨组织成骨相关通路上调及线粒体自噬活性增加。
- 免疫荧光证实PTHLH组线粒体与溶酶体标志物共定位增强,主要位于骨膜。
- 慢病毒过表达Pthlh促进原代大鼠骨膜干细胞增殖迁移及COL1A1、BNIP3和LC3-II表达,Mdivi-1可减轻这些效应。
临床怎么用
- 局部rAAV9-Pthlh注射可能作为增厚牙槽骨、预防骨开裂的候选生物制剂策略。
- 在正畸扩弓等干预前预防性注射可能有助于保护牙槽嵴。
局限性
- 研究基于大鼠模型,尚未在人体验证。
- 机制涉及线粒体自噬依赖的线粒体稳态维持,但具体调控网络仍需进一步阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alveolar bone regions with low innate thickness are prone to dehiscence, potentially causing harmful gingival recession. In situ alveolar bone thickening via local bioagent administration has recently emerged as a promising research area. Parathyroid hormone-related protein (PTHrP), encoded by the Pthlh gene, plays a pivotal role in skeletal development and bone remodeling. In this study, we developed a recombinant adeno-associated virus (rAAV) vector overexpressing Pthlh (rAAV9-Pthlh). Using a split-mouth design, we administered rAAV9-Pthlh via a single submucosal injection into the right maxillary buccal gingiva of rats. Micro-computed tomography scans, both in vivo and ex vivo, revealed a significant increase in alveolar bone thickness on the PTHLH sides 6 wk post-transfection. This enhanced alveolar bone formation was accompanied by marked periosteal thickening, with elevated expression of PTHrP, parathyroid hormone 1 receptor (PTH1R), OCN, and COL1A1. RNA sequencing of the buccal bone tissue showed upregulation of osteogenesis-related pathways along with increased mitophagy activity. Immunofluorescence confirmed enhanced colocalization of mitochondrial and lysosomal markers in the PTHLH group, primarily in the periosteum. Overexpressing Pthlh in primary rat periosteal stem cells via lentiviral transduction promoted cell proliferation and migration and elevated expression of COL1A1, as well as mitophagy markers BNIP3 and LC3-II. These effects were mitigated by Mdivi-1, an inhibitor of mitochondrial fission, suggesting potential involvement of mitophagy-dependent mitochondrial homeostasis maintenance. Finally, we established a rat model of repeated maxillary expansion and validated the effects of prophylactic rAAV9-Pthlh injection to protect against alveolar crest loss in this scenario. In conclusion, local rAAV9-Pthlh injection enhances in situ alveolar bone formation, holding potential for preventing dehiscence in aging or following orthodontic interventions. Additionally, overexpression of PTHrP in the alveolar periosteum has reiterated its well-documented role in expanding the pool of chondroskeletal progenitors, a process vital for the development of long bones and the mandibular condyle.
引用
- Chen Y, Zhang B, Li B, et al. PTHrP Overexpression in Periosteum Promotes Alveolar Bone Formation. J Dent Res. 2026. PMID: 42198992. doi:10.1177/00220345261443475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。